KJIM :: Korean Journal of Internal Medicine

Ticagrelor monotherapy after a short course of dual antiplatelet therapy with ticagrelor plus aspirin following percutaneous coronary intervention in patients with versus without diabetes mellitus: a meta-analysis of randomized trials

BMC Cardiovascular Disorders.2024;[Epub] CrossRef

Treatment of the New Era: Long-Term Ticagrelor Monotherapy for the Treatment of Patients with Type 2 Diabetes Mellitus following Percutaneous Coronary Intervention: A Meta-analysis

Hong Wang, Xiaoya Xie, Quannan Zu, Ming Lu, Rongfa Chen, Zhiren Yang, Yongqiang Gao, Zhangui Tang

Long-term cardiovascular outcomes of biodegradable polymer drug eluting stents in patients with diabetes versus non-diabetes mellitus: a meta-analysis

Hong Wang, Quannan Zu, Hairong Tang, Ming Lu, Rongfa Chen, Zhiren Yang

Cardiovascular Diabetology.2023;[Epub] CrossRef

Cangrelor or Clopidogrel in Patients with Type 2 Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials

Hongtao Lu, Wenjun Guan, Yanhua Zhou, Zhangui Tang, Hong Bao

Platelet Function Testing for Cardiac Surgery Patients on Antiplatelet Therapy: The Extreme Variability of Point-Of-Care Tests

Biomedical and Pharmacology Journal.2018; 11(2): 593. CrossRef

A pharmacodynamic study of the optimal P2Y<sub>12</sub> inhibitor regimen for East Asian patients with acute coronary syndrome

Ji Hyun Lee, Sung Gyun Ahn, Bonil Park, Sang Wook Park, Yong Seok Kang, Jun-Won Lee, Young Jin Youn, Min-Soo Ahn, Jang-Young Kim, Byung-Su Yoo, Seung-Hwan Lee, Junghan Yoon

The Korean Journal of Internal Medicine.2015; 30(5): 620. CrossRef

Comparing the effectiveness and safety between triple antiplatelet therapy and dual antiplatelet therapy in type 2 diabetes mellitus patients after coronary stents implantation: a systematic review and meta-analysis of randomized controlled trials

BMC Cardiovascular Disorders.2015;[Epub] CrossRef

Thrombin Generation and Platelet Reactivity at Hospital Discharge and 6-Month Outcome after the Acute Coronary Syndrome in Diabetic and Nondiabetic Patients

Wiktor Kuliczkowski, Marta Szewczyk, Jacek Kaczmarski, Ewa Sztohryn, Małgorzata Greif, Damian Pres, Seth D. Fortmann, Lech Poloński, Victor Serebruany

Comparison of Antiplatelet Effect and Safety of Clopidogrel Napadisilate with Clopidogrel Bisulfate in Coronary Artery Disease Patients: Multi-center, Randomized, Double-blind, Phase IV, Non-inferiority Clinical Trial

Sahmin Lee, Hae-Young Lee, Kyung-Woo Park, Hyun-Jae Kang, Bon-Kwon Koo, Hyo-Soo Kim, Dong-Ju Choi, Myung-A Kim, Byung-Hee Oh

American Journal of Cardiovascular Drugs.2013; 13(6): 413. CrossRef

Comparison of On-Treatment Platelet Reactivity Between Triple Antiplatelet Therapy With Cilostazol and Standard Dual Antiplatelet Therapy in Patients Undergoing Coronary Interventions

Hemang B. Panchal, Tejaskumar Shah, Parthavkumar Patel, Kais Albalbissi, Janos Molnar, Brandon Coffey, Sandeep Khosla, Vijay Ramu

Journal of Cardiovascular Pharmacology and Therapeutics.2013; 18(6): 533. CrossRef

Dual Antiplatelet Therapy Clopidogrel with Low-dose Cilostazol Intensifies Platelet Inhibition in Patients with Ischemic Stroke

Hajime Maruyama, Takuya Fukuoka, Ichiro Deguchi, Yasuko Ohe, Harumitsu Nagoya, Yuji Kato, Yohsuke Horiuchi, Takeshi Hayashi, Norio Tanahashi